Apollo Biowellness Inc (KOAN) Stock Price & News

All values in USD	2024 оны 9-р сар	2024 оны 12-р сар	2025 оны 3-р сар
Revenue	598.63 мян	546.31 мян	430.77 мян
Cost of goods sold	179.16 мян	182.94 мян	140.72 мян
Cost of revenue	179.16 мян	182.94 мян	140.72 мян
Research and development expenses	3.51 мян	-	-
Total research and development expenses	-	-	-
Selling, general, and admin expenses	685.72 мян	714.03 мян	620.28 мян
Operating expense	689.23 мян	714.03 мян	620.28 мян
Total operating expenses	868.38 мян	896.97 мян	761.01 мян
Operating income	-269.76 мян	-350.66 мян	-330.24 мян
Other non operating income	-	3.37 мян	215.00
EBT including unusual items	-305.50 мян	-577.44 мян	-411.82 мян
EBT excluding unusual items	-273.04 мян	-577.44 мян	-411.82 мян
Income tax expense	-	-	-
Effective tax rate	-	-	-
Other operating expenses	-	-	-
Net income	-305.50 мян	-577.44 мян	-411.82 мян
Net profit margin	-51.03%	-105.70%	-95.60%
Earnings per share	-	-	-
Interest and investment income	-	-	-
Interest expense	-3.28 мян	-230.15 мян	-81.79 мян
Net interest expenses	-3.28 мян	-230.15 мян	-81.79 мян
Depreciation and amortization charges	-	-	-
EBITDA	-269.76 мян	-350.66 мян	-325.96 мян
Gain or loss from assets sale	69.24 мян	-	-

Ask anything